131 related articles for article (PubMed ID: 4849379)
1. [Pharmacodynamic study of a new vasodilator, cinepazide maleate I -Vasodilating action].
Pourrias B; Bouvet P; Raynaud G
Therapie; 1974; 29(1):29-41. PubMed ID: 4849379
[No Abstract] [Full Text] [Related]
2. [Pharmacodynamic study of a new vasodilatator, cinepazide maleate. II. Action on general and cardiac hemodynamics, respiration and diuresis. Local anesthetic action and effect on the autonomic nervous system. Prolonged toxicity].
Pourrias B; Bailly Y; Sergant M; Bouvet P; Raynaud G
Therapie; 1974; 29(1):43-50. PubMed ID: 4849378
[No Abstract] [Full Text] [Related]
3. Effects of cinepazide, a new vasoactive substance, on heart and circulation in the dog.
Brückner UB; Schmier J
Arzneimittelforschung; 1976; 26(8):1565-8. PubMed ID: 1036953
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacodynamic aspects of a new coronary dilator: (3,4,5, trimethoxycinnamoil)-1 (ethylacetate)-4-piperazine maleate (6753)].
Marmo E; Caputi A
Boll Soc Ital Cardiol; 1971; 16(9):523-30. PubMed ID: 5150376
[No Abstract] [Full Text] [Related]
5. [Pharmacodynamic study of a new cardiovascular drug: 4-(3',4',5'-trimethoxycinnamoyl)-1-(N-isopropylcarbamoylmethyl) piperazine maleate].
Pourrias B; Bouvet P; Raynaud G
Therapie; 1974; 29(2):233-50 passim. PubMed ID: 4849377
[No Abstract] [Full Text] [Related]
6. [The effects of cinepazide on cerebral circulation (author's transl)].
Baba M; Kitamura K
No To Shinkei; 1979 Jun; 31(6):621-9. PubMed ID: 465204
[No Abstract] [Full Text] [Related]
7. [Effect of 1-[(1-pyrrolidynylcarbonyl) methyl]-4-(3, 4, 5-trimethoxycinnamoyl)piperazine maleate (cinepazide) on cerebral and peripheral circulation in cats (author's transl)].
Hirohashi M; Hagihara Y
Nihon Yakurigaku Zasshi; 1979 Jul; 75(5):495-506. PubMed ID: 540881
[TBL] [Abstract][Full Text] [Related]
8. [Agents to improve cerebrovascular circulation and cerebral metabolism--cinepazide].
Fujishima M
Nihon Rinsho; 1985 Feb; 43(2):379-82. PubMed ID: 3999408
[No Abstract] [Full Text] [Related]
9. [Cardiovascular pharmacology of cinepazide, a new cerebral vasodilator (author's transl)].
Akashi A; Hirohashi M; Suzuki I; Shibamura S; Kasahara A
Nihon Yakurigaku Zasshi; 1979 Jul; 75(5):507-16. PubMed ID: 540882
[TBL] [Abstract][Full Text] [Related]
10. Experimental investigation of 4-(3',4',5'-trimethoxycinnamoyl)-1-piperaziny l-pyrrolidinyl maleate (67350): effect on the cardiovascular system and on certain smooth muscles.
Marmo E; Caputi AP; Cataldi S
Farmaco Prat; 1973 Mar; 28(3):132-60. PubMed ID: 4691581
[No Abstract] [Full Text] [Related]
11. Effects of intravenously and orally administered cinpropazide on the coronary circulation in unanesthetized and unrestrained dogs.
Nonaka K; Ueno A
Arzneimittelforschung; 1985; 35(10):1499-502. PubMed ID: 4074404
[TBL] [Abstract][Full Text] [Related]
12. [Cineangiographic method for the pharmacodynamic study of the coronary circulation in the dog. Application to derivatives of the cinnamoyl-piperazine series].
Pernod J; Pourrias B; Haguenauer G; Siau J
Therapie; 1972; 27(1):85-91. PubMed ID: 5017557
[No Abstract] [Full Text] [Related]
13. [General pharmacology of a new substance derived from cinnamoyl piperazine. II. Action on general circulation and the autonomic nervous system. Other pharmacological properties].
Pourrias B; Dorme N; Bouvet P; Raynaud G
Therapie; 1971; 26(4):859-72. PubMed ID: 5119135
[No Abstract] [Full Text] [Related]
14. [General pharmacology of a new substance derived from cinnamoyl piperazine. I. Toxicological study. Action on coronary circulation and on myocardial metabolism].
Pourrias B; Bailly Y; Sergant M; Bouvet P; Raynaud G
Therapie; 1971; 26(4):845-57. PubMed ID: 5119134
[No Abstract] [Full Text] [Related]
15. Effects and mechanism of action of trimazosin on coronary and left ventricular dynamics in conscious dogs.
Macho P; Vatner SF
J Pharmacol Exp Ther; 1981 May; 217(2):333-9. PubMed ID: 7229975
[No Abstract] [Full Text] [Related]
16. Benzylpiperazine derivatives. VI. Design and syntheses of vinylogs of 1-benzyl-4-diphenylmethylpiperazine derivatives and their cerebral vasodilating activities.
Ohtaka H; Kanazawa T; Ito K; Tsukamoto G
Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4124-9. PubMed ID: 3435938
[No Abstract] [Full Text] [Related]
17. Clinical evaluation of cinnarizine in patients with cerebral circulatory deficiency.
Toledo JB; Pisa H; Marchese M
Arzneimittelforschung; 1972 Feb; 22(2):448-51. PubMed ID: 4554633
[No Abstract] [Full Text] [Related]
18. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of various coronary dilators following enteral application in the anesthetized dog].
Lorenz D; Dell HD
Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):272-3. PubMed ID: 4242418
[No Abstract] [Full Text] [Related]
20. Cerebral and coronary vascular effects of a symmetrical N,N'-disubstituted hexahydrodiazepine.
Buyniski JP; Losada M; Bierwagen ME; Gardier RW
J Pharmacol Exp Ther; 1972 Jun; 181(3):522-8. PubMed ID: 5033017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
